<DOC>
	<DOCNO>NCT01144286</DOCNO>
	<brief_summary>In order find optimal dose arasertaconazole nitrate treatment vulvovaginal candidiasis , multicenter , randomize , double-blind , parallel , placebo-controlled study conduct compare therapeutic efficacy , safety tolerability three different dos arasertaconazole nitrate ( 150 mg , 300 mg 600 mg , pessary ) .</brief_summary>
	<brief_title>Arasertaconazole Nitrate Pessaries - Dose Finding Study Vulvovaginal Candidiasis ( VVC ) Treatment</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<criteria>Women age 18 65 year age sign informed consent . Not pregnant , nursing . No indication vulvovaginitis genital infection Positive 10 % potassium hydroxide ( KOH ) preparation bud yeast and/or pseudohyphae . Negative wet mount result T. vaginalis clue cell . Subjects another vaginal vulvar condition would confound interpretation clinical response . Hypersensitivity imidazole product administer topically . Any medical condition opinion investigator could interfere study conduct .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>VVC</keyword>
	<keyword>candidiasis</keyword>
	<keyword>vaginal candidiasis</keyword>
</DOC>